6-K Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 Q2 2018

Filing Information

Form Type	6-K
Accession Number	`0001213900-18-012842`
Period End Date	20180630
Filing Date	20180921
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	clgn-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 76 Cash Flow Statement 97 Stockholders Equity 27

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalents`	$2.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$4.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	4.54M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$1.32M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	9.36M	ILS	Point-in-time
Trade receivables	`TradeReceivables`	1.54M	ILS	Point-in-time
Trade receivables	`TradeReceivables`	354,000.00	ILS	Point-in-time
Trade receivables	`TradeReceivables`	$423.00K	USD	Point-in-time
Other	`OtherCurrentReceivables`	2.14M	ILS	Point-in-time
Other	`OtherCurrentReceivables`	$587.00K	USD	Point-in-time
Other	`OtherCurrentReceivables`	3.54M	ILS	Point-in-time
Inventory	`Inventories`	$642.00K	USD	Point-in-time
Inventory	`Inventories`	2.35M	ILS	Point-in-time
Inventory	`Inventories`	700,000.00	ILS	Point-in-time
Total current assets	`CurrentAssets`	15.40M	ILS	Point-in-time
Total current assets	`CurrentAssets`	22.41M	ILS	Point-in-time
Total current assets	`CurrentAssets`	$4.22M	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	503,000.00	ILS	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$145.00K	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	530,000.00	ILS	Point-in-time
Long-term receivables	`NoncurrentAssetsLongTermReceivables`	$43.00K	USD	Point-in-time
Long-term receivables	`NoncurrentAssetsLongTermReceivables`	157,000.00	ILS	Point-in-time
Long-term receivables	`NoncurrentAssetsLongTermReceivables`	92,000.00	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$1.48M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	3.58M	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	5.40M	ILS	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	1.36M	ILS	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	$373.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	1.45M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	$2.04M	USD	Point-in-time
Total non-current assets	`NoncurrentAssets`	7.45M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	5.63M	ILS	Point-in-time
TOTAL ASSETS	`Assets`	22.85M	ILS	Point-in-time
TOTAL ASSETS	`Assets`	$6.26M	USD	Point-in-time
TOTAL ASSETS	`Assets`	28.05M	ILS	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	2.35M	ILS	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$643.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	2.92M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	2.00M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	1.55M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$425.00K	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$1.07M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	3.90M	ILS	Point-in-time
Total current liabilities	`CurrentLiabilities`	4.92M	ILS	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	12.64M	ILS	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	-	ILS	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	-	USD	Point-in-time
Warrants at fair value	`NonCurrentWarrantsAtFairValue`	4.62M	ILS	Point-in-time
Warrants at fair value	`NonCurrentWarrantsAtFairValue`	$1.27M	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$23.00K	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	84,000.00	ILS	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	141,000.00	ILS	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	1.20M	ILS	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	$299.00K	USD	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	1.09M	ILS	Point-in-time
Loan	`LongtermBorrowings`	210,000.00	ILS	Point-in-time
Loan	`LongtermBorrowings`	$58.00K	USD	Point-in-time
Long-term payables	`LongTermPayables`	-	ILS	Point-in-time
Long-term payables	`LongTermPayables`	-	USD	Point-in-time
Long-term payables	`LongTermPayables`	61,000.00	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	14.04M	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	6.01M	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$1.65M	USD	Point-in-time
Total liabilities	`Liabilities`	18.96M	ILS	Point-in-time
Total liabilities	`Liabilities`	$2.71M	USD	Point-in-time
Total liabilities	`Liabilities`	9.91M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	5.13M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	5.00M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	$1.41M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	178.47M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	192.87M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$52.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-50.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	-185.06M	ILS	Point-in-time
Accumulated deficit	`RetainedEarnings`	-174.38M	ILS	Point-in-time
TOTAL EQUITY	`Equity`	$2.49M	USD	Point-in-time
TOTAL EQUITY	`Equity`	5.58M	ILS	Point-in-time
TOTAL EQUITY	`Equity`	5.16M	ILS	Point-in-time
TOTAL EQUITY	`Equity`	$3.54M	USD	Point-in-time
TOTAL EQUITY	`Equity`	9.08M	ILS	Point-in-time
TOTAL EQUITY	`Equity`	12.94M	ILS	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	$6.26M	USD	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	22.85M	ILS	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	28.05M	ILS	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenue`	653,000.00	ILS	1 Quarter
Revenue	`Revenue`	1.43M	ILS	2 Qtrs
Revenue	`Revenue`	$170.00K	USD	1 Quarter
Revenue	`Revenue`	453,000.00	ILS	2 Qtrs
Revenue	`Revenue`	$392.00K	USD	2 Qtrs
Revenue	`Revenue`	201,000.00	ILS	1 Quarter
Cost of Revenue	`CostOfSales`	-	ILS	2 Qtrs
Cost of Revenue	`CostOfSales`	324,000.00	ILS	2 Qtrs
Cost of Revenue	`CostOfSales`	238,000.00	ILS	1 Quarter
Cost of Revenue	`CostOfSales`	$89.00K	USD	2 Qtrs
Cost of Revenue	`CostOfSales`	-	ILS	1 Quarter
Cost of Revenue	`CostOfSales`	$65.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	201,000.00	ILS	1 Quarter
Gross Profit	`GrossProfit`	415,000.00	ILS	1 Quarter
Gross Profit	`GrossProfit`	1.11M	ILS	2 Qtrs
Gross Profit	`GrossProfit`	$303.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$105.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	453,000.00	ILS	2 Qtrs
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	2.33M	ILS	1 Quarter
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	6.80M	ILS	2 Qtrs
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	$591.00K	USD	1 Quarter
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	$1.86M	USD	2 Qtrs
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	8.34M	ILS	2 Qtrs
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	4.30M	ILS	1 Quarter
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$812.00K	USD	1 Quarter
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$1.79M	USD	2 Qtrs
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	3.09M	ILS	1 Quarter
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	1.59M	ILS	1 Quarter
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	2.93M	ILS	2 Qtrs
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	6.54M	ILS	2 Qtrs
Total operating costs and expenses:	`OperatingExpense`	5.89M	ILS	1 Quarter
Total operating costs and expenses:	`OperatingExpense`	$3.65M	USD	2 Qtrs
Total operating costs and expenses:	`OperatingExpense`	5.43M	ILS	1 Quarter
Total operating costs and expenses:	`OperatingExpense`	13.34M	ILS	2 Qtrs
Total operating costs and expenses:	`OperatingExpense`	$1.40M	USD	1 Quarter
Total operating costs and expenses:	`OperatingExpense`	11.27M	ILS	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	-5.01M	ILS	1 Quarter
Operating loss	`ProfitLossFromOperatingActivities`	-12.23M	ILS	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	$-3.35M	USD	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	$-1.30M	USD	1 Quarter
Operating loss	`ProfitLossFromOperatingActivities`	-10.82M	ILS	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	-5.69M	ILS	1 Quarter
Financial income	`FinanceIncome`	-	ILS	1 Quarter
Financial income	`FinanceIncome`	$18.00K	USD	1 Quarter
Financial income	`FinanceIncome`	469,000.00	ILS	2 Qtrs
Financial income	`FinanceIncome`	-	ILS	2 Qtrs
Financial income	`FinanceIncome`	$128.00K	USD	2 Qtrs
Financial income	`FinanceIncome`	82,000.00	ILS	1 Quarter
Financial expenses	`FinanceCosts`	646,000.00	ILS	1 Quarter
Financial expenses	`FinanceCosts`	$173.00K	USD	1 Quarter
Financial expenses	`FinanceCosts`	220,000.00	ILS	2 Qtrs
Financial expenses	`FinanceCosts`	1.05M	ILS	2 Qtrs
Financial expenses	`FinanceCosts`	$289.00K	USD	2 Qtrs
Financial expenses	`FinanceCosts`	159,000.00	ILS	1 Quarter
Financial expenses, net	`FinanceIncomeCost`	$-155.00K	USD	1 Quarter
Financial expenses, net	`FinanceIncomeCost`	-220,000.00	ILS	2 Qtrs
Financial expenses, net	`FinanceIncomeCost`	-585,000.00	ILS	2 Qtrs
Financial expenses, net	`FinanceIncomeCost`	-159,000.00	ILS	1 Quarter
Financial expenses, net	`FinanceIncomeCost`	$-161.00K	USD	2 Qtrs
Financial expenses, net	`FinanceIncomeCost`	-564,000.00	ILS	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	-11.04M	ILS	2 Qtrs
Comprehensive loss	`ComprehensiveIncome`	-5.84M	ILS	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	-5.58M	ILS	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	-12.82M	ILS	2 Qtrs
Comprehensive loss	`ComprehensiveIncome`	$-1.45M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	$-3.51M	USD	2 Qtrs
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	$0.02	USD	2 Qtrs
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.06	ILS	2 Qtrs
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.03	ILS	1 Quarter
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	$0.01	USD	1 Quarter
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.09	ILS	2 Qtrs
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.04	ILS	1 Quarter
Weighted average ordinary shares outstanding	`WeightedAverageShares`	206.88M	shares	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageShares`	217.43M	shares	1 Quarter
Weighted average ordinary shares outstanding	`WeightedAverageShares`	124.50M	shares	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageShares`	130.60M	shares	1 Quarter

Cash Flow Statement 97 line items

Line Item	Tag	Value	Unit	Period
Comprehensive loss	`ComprehensiveIncome`	-11.04M	ILS	2 Qtrs
Comprehensive loss	`ComprehensiveIncome`	-5.84M	ILS	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	-5.58M	ILS	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	-12.82M	ILS	2 Qtrs
Comprehensive loss	`ComprehensiveIncome`	$-1.45M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	$-3.51M	USD	2 Qtrs
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	601,000.00	ILS	2 Qtrs
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$164.00K	USD	2 Qtrs
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	600,000.00	ILS	2 Qtrs
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	$588.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	1.06M	ILS	2 Qtrs
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	2.14M	ILS	2 Qtrs
Changes in fair market value of services received through the Alpha Agreement	`AdjustmentsForIncreaseDecreaseInFairMarketValueOfServicesReceived`	-	ILS	2 Qtrs
Changes in fair market value of services received through the Alpha Agreement	`AdjustmentsForIncreaseDecreaseInFairMarketValueOfServicesReceived`	1.53M	ILS	2 Qtrs
Changes in fair market value of services received through the Alpha Agreement	`AdjustmentsForIncreaseDecreaseInFairMarketValueOfServicesReceived`	$419.00K	USD	2 Qtrs
Recognition of unrecognized day one loss	`AdjustmentsForRecognitionOfUnrecognizedDayOneLoss`	$119.00K	USD	2 Qtrs
Recognition of unrecognized day one loss	`AdjustmentsForRecognitionOfUnrecognizedDayOneLoss`	433,000.00	ILS	2 Qtrs
Recognition of unrecognized day one loss	`AdjustmentsForRecognitionOfUnrecognizedDayOneLoss`	-	ILS	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalentsOperationActivities`	-59,000.00	ILS	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalentsOperationActivities`	$-16.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalentsOperationActivities`	75,000.00	ILS	2 Qtrs
Loss from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	589,000.00	ILS	2 Qtrs
Loss from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	$161.00K	USD	2 Qtrs
Loss from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-	ILS	2 Qtrs
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	-27,000.00	ILS	2 Qtrs
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	$-7.00K	USD	2 Qtrs
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	50,000.00	ILS	2 Qtrs
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-9.26M	ILS	2 Qtrs
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-7.61M	ILS	2 Qtrs
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	$-2.08M	USD	2 Qtrs
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-1.19M	ILS	2 Qtrs
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-326.00K	USD	2 Qtrs
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-	ILS	2 Qtrs
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-1.65M	ILS	2 Qtrs
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-63,000.00	ILS	2 Qtrs
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-451.00K	USD	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	$-54.00K	USD	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	2.76M	ILS	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	-196,000.00	ILS	2 Qtrs
(Decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	-507,000.00	ILS	2 Qtrs
(Decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	$-139.00K	USD	2 Qtrs
(Decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	-3.00M	ILS	2 Qtrs
Decrease (increase) in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$-122.00K	USD	2 Qtrs
Decrease (increase) in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	169,000.00	ILS	2 Qtrs
Decrease (increase) in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	-446,000.00	ILS	2 Qtrs
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	-111,000.00	ILS	2 Qtrs
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	$-30.00K	USD	2 Qtrs
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	-26,000.00	ILS	2 Qtrs
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	-161,000.00	ILS	2 Qtrs
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	$-1.12M	USD	2 Qtrs
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	-4.09M	ILS	2 Qtrs
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-9.42M	ILS	2 Qtrs
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-11.71M	ILS	2 Qtrs
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-3.21M	USD	2 Qtrs
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	2.33M	ILS	2 Qtrs
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	45,000.00	ILS	2 Qtrs
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$638.00K	USD	2 Qtrs
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-45,000.00	ILS	2 Qtrs
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-2.33M	ILS	2 Qtrs
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-638.00K	USD	2 Qtrs
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssuingShares`	6.79M	ILS	2 Qtrs
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssuingShares`	5.44M	ILS	2 Qtrs
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssuingShares`	$1.49M	USD	2 Qtrs
Exercise of warrants into shares	`ProceedsFromExerciseOfOptions`	3.62M	ILS	2 Qtrs
Exercise of warrants into shares	`ProceedsFromExerciseOfOptions`	-	USD	2 Qtrs
Exercise of warrants into shares	`ProceedsFromExerciseOfOptions`	-	ILS	2 Qtrs
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	$58.00K	USD	2 Qtrs
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	-	ILS	2 Qtrs
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	210,000.00	ILS	2 Qtrs
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	126,000.00	ILS	2 Qtrs
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	127,000.00	ILS	2 Qtrs
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	$35.00K	USD	2 Qtrs
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$1.51M	USD	2 Qtrs
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	10.28M	ILS	2 Qtrs
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	5.52M	ILS	2 Qtrs
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	-8.51M	ILS	2 Qtrs
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	$-2.33M	USD	2 Qtrs
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	818,000.00	ILS	2 Qtrs
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$1.32M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	9.36M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$4.88M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$2.56M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	4.54M	ILS	Point-in-time
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$16.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	-75,000.00	ILS	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	59,000.00	ILS	2 Qtrs
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$2.56M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$4.88M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	4.54M	ILS	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$1.32M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	9.36M	ILS	Point-in-time
Conversion of Debentures to pre-paid warrant	`IssueOfConvertibleInstruments`	$3.48M	USD	2 Qtrs
Conversion of Debentures to pre-paid warrant	`IssueOfConvertibleInstruments`	12.71M	ILS	2 Qtrs

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Issue of shares and warrants, net of issue expenses	`IssuanceOfSharesAndWarrantsNetOfIssueExpenses`	350,000.00	ILS	2 Qtrs
Issue of shares and warrants, net of issue expenses	`IssuanceOfSharesAndWarrantsNetOfIssueExpenses`	$96.00K	USD	2 Qtrs
Issue of shares and warrants, net of issue expenses	`IssuanceOfSharesAndWarrantsNetOfIssueExpenses`	404,000.00	ILS	2 Qtrs
Balance	`Equity`	5.58M	ILS	Point-in-time
Balance	`Equity`	5.16M	ILS	Point-in-time
Balance	`Equity`	$3.54M	USD	Point-in-time
Balance	`Equity`	9.08M	ILS	Point-in-time
Balance	`Equity`	$2.49M	USD	Point-in-time
Balance	`Equity`	12.94M	ILS	Point-in-time
Comprehensive loss	`ProfitLoss`	-11.04M	ILS	2 Qtrs
Comprehensive loss	`ProfitLoss`	$-3.51M	USD	2 Qtrs
Comprehensive loss	`ProfitLoss`	-12.82M	ILS	2 Qtrs
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	1.06M	ILS	2 Qtrs
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$588.00K	USD	2 Qtrs
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	2.14M	ILS	2 Qtrs
Conversion of Debentures to Prepaid warrants	`IssueOfConvertibleInstruments`	$3.48M	USD	2 Qtrs
Conversion of Debentures to Prepaid warrants	`IssueOfConvertibleInstruments`	12.71M	ILS	2 Qtrs
Issue of shares and warrants, net of issue expenses	`IssuanceOfSharesAndWarrants`	1.82M	ILS	2 Qtrs
Issue of shares and warrants, net of issue expenses	`IssuanceOfSharesAndWarrants`	$498.00K	USD	2 Qtrs
Issue of shares and warrants, net of issue expenses	`IssuanceOfSharesAndWarrants`	6.79M	ILS	2 Qtrs
Exercise of warrants into shares	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	3.62M	ILS	2 Qtrs
Balance	`Equity`	5.58M	ILS	Point-in-time
Balance	`Equity`	5.16M	ILS	Point-in-time
Balance	`Equity`	$3.54M	USD	Point-in-time
Balance	`Equity`	9.08M	ILS	Point-in-time
Balance	`Equity`	$2.49M	USD	Point-in-time
Balance	`Equity`	12.94M	ILS	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.